FDA.reportPublic FDA data

dapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet

RxCUI
1925498
RxNorm name
dapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet
Display name
dapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet
Full name
dapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DAPAGLIFLOZIN AND SAXAGLIPTINDAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLC1cfa51fd-8406-404c-b2a8-0fc1068675fb2026-04-08Warnings, Adverse reactionsExact identifier
rxcui: 1925498

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1cfa51fd-8406-404c-b2a8-0fc1068675fbdapagliflozin 10 MG / sAXagliptin 5 MG Oral TabletPSN1These highlights do not include all the information needed to use DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS. DAPAGLIFLOZIN AND SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 201720260408
1cfa51fd-8406-404c-b2a8-0fc1068675fbdapagliflozin 10 MG (as dapagliflozin propanediol 12.3 MG) / saxagliptin 5 MG (as saxagliptin HCl 5.95 MG) Oral TabletSY1These highlights do not include all the information needed to use DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS. DAPAGLIFLOZIN AND SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 201720260408
1cfa51fd-8406-404c-b2a8-0fc1068675fbdapagliflozin 10 MG / saxagliptin 5 MG Oral TabletSCD1These highlights do not include all the information needed to use DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS. DAPAGLIFLOZIN AND SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 201720260408